Skip to main content
Glama

Nihr

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only idempotent annotations, the description discloses soft-fail behavior (USPTO PatentsView sunset), expected empty results for fda_products, the meaning of sources_used/sources_failed ('an empty section is a real no data, not a bug'), and resolution semantics for private companies. It also notes the GDELT→GNews fallback.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with the core purpose and example queries, followed by source enumeration and edge-case handling. Every sentence carries operational value, though its density and single-paragraph format make it slightly harder to scan.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates by enumerating return sections (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/failed) and explaining edge cases. It leaves little ambiguity for an agent deciding whether and how to call the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema already covers both parameters (100%), the description enriches them with concrete examples (AAPL, 0000320193, Moderna), explains that type is interchangeable, and details name resolution via SEC EDGAR and the resolved:false behavior.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user queries and states 'full cross-source profile of a US public company in ONE parallel call', making the tool's purpose unmistakable. It distinguishes itself from 'chaining single-pack SEC/XBRL/news lookups' and from siblings like resolve_entity and deep_research by focusing on holistic company profiling.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also provides example phrasings and clarifies input forms, so an agent knows exactly when to invoke this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Nihr toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

The set contains several clusters of near-overlapping tools: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, ask_pipeworx/deep_research/validate_claim all handle natural-language queries, and bet_research/polymarket_edges/polymarket_arbitrage scan the same prediction-market space. The descriptions are detailed, but that does not remove the boundary confusion.

Naming Consistency4/5

Almost all tools use lowercase snake_case with recognizable patterns such as verb_noun or prefix_domain (nihr_, polymarket_, pipeworx_). There are minor deviations like ask_pipeworx_beta vs ask_pipeworx_grounded and mixed noun/verb phrasing, but the naming is predictable overall.

Tool Count2/5

36 tools is beyond the typical well-scoped server size, and the set reads as several products bundled together: NIHR grants, Pipeworx data research, prediction markets, memory, subscriptions, and standalone utilities like generate_llms_txt or scan_dependency. Even for a broad data platform this is too many to navigate coherently, and it is a severe mismatch for a server named 'Nihr'.

Completeness3/5

Within its subdomains the set covers core workflows: query (ask/deep_research/validate), entity resolution/profile/comparison, NIHR grant lookup by several dimensions, prediction-market analysis through fill-risk, and memory/subscription lifecycles. But it is a collection of partial products rather than one coherent domain, and some outputs such as pipeworx:// citations or detected arbitrage opportunities lack an obvious in-set tool to consume them further.

Resources